{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:29:02Z","timestamp":1792096142565,"version":"4.4.0"},"reference-count":31,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"\n Background:<\/jats:title>\n Patients diagnosed with pituitary apoplexy and presenting with acute visual deterioration require urgent surgical resection. This is also commonly associated with pituitary hypopituitarism that requires hormonal replacement for correction. This study was undertaken to evaluate the clinical recovery of 45 patients diagnosed with symptomatic pituitary apoplexy who underwent early (within 72 h of symptom onset) endoscopic transsphenoidal surgical resection with an emphasis on visual, ocular craniopathy, and endocrinological outcome.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n This is a retrospective analysis of a consecutive series of patients diagnosed with pituitary apoplexy between 2011 and 2020 treated by early (within 72 h of symptom onset) endoscopic transsphenoidal surgical resection. All tumors were histologically proven as pituitary adenomas. Clinical and neuro-ophthalmological examinations, imaging studies, and endocrinological evaluation were retrospectively reviewed. Patients with a minimum of 6 months follow-up were included in the study. The influence of patients\u2019 demographics, extent of visual and ocular motility impairment, preoperative endocrinological dysfunction, tumor size and extent, degree of resection, and surgical complications were analyzed as potential prognostic factors for recovery.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Forty-five patients were included in this retrospective study. Ages ranged from 27 to 57 years (mean: 42 years). All patients presented with headache and variable degrees of visual loss and visual field deficit. Ophthalmoplegia was present in 22 (48.9%) patients with 17 (37.8%) having bilateral ocular cranial nerve palsy. All patients had variable degrees of endocrinological deficiencies. All patients showed evidence of low cortisol, 14 (31.1%) showed hypothyroidism and 11 (24.4%) showed hypogonadism. There was evidence of hyperprolactinemia in 16 (35.6%) patients. All patients harbored a pituitary macroadenoma. Tumor resection was complete in 33 (73%) of patients, with residual tumor related to cavernous sinus or retrosellar extension. Operative complications were mainly related to short-term nasal complications occurring in 14 (31%) patients. Cerebrospinal fluid leak requiring revision surgery occurred in only one patient harboring a modified SIPAP Grade 3s tumor. Transient diabetes insipidus occurred in 9 (20%) patients, with 2 (4.4%) requiring long-term hormonal replacement. The mean follow-up was 25 months. Baseline visual improvement was achieved in 39 (86.7%) patients. Ocular cranial nerve palsy showed complete recovery in 17 (77.2%) patients. Endocrine follow-up showed that patients with panhypopituitarism (11 [24.4%]) failed to recover.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n The current surgical series showed safety in terms of low complication rate and efficacy in terms of clinical outcome. The significant prognostic factor related to visual recovery was the degree of preoperative visual deficit. Recovery of ocular cranial neuropathy showed a higher recovery rate when it was unilateral as opposed to bilateral. Pituitary hormonal recovery was less favorable with pituitary panhypopituitarism being a poor prognostic factor.<\/jats:p>\n <\/jats:sec>","DOI":"10.25259\/sni_642_2022","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T04:58:57Z","timestamp":1663909137000},"page":"433","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Determinants of visual and endocrinological outcome after early endoscopic endonasal surgery for pituitary apoplexy"],"prefix":"10.25259","volume":"13","author":[{"given":"Ahmed","family":"Galal","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Ain Shams University, Cairo, Egypt,"},{"name":"Department of Neurosurgery, Dr Erfan and Bagedo General Hospital, Jeddah, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar El Farouk","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ain Shams University, Cairo, Egypt,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"10.25259\/SNI_642_2022\/ref-1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/2152-7806.199557","article-title":"The impact of surgical timing on visual outcome in pituitary apoplexy: Literature review and case illustration","volume":"8","author":"Abdulbaki","year":"2017","journal-title":"Surg Neurol Int"},{"key":"10.25259\/SNI_642_2022\/ref-2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bmj.329.7459.218","article-title":"Acute visual loss and pituitary apoplexy after surgery","volume":"329","author":"Abott","year":"2004","journal-title":"BMJ"},{"key":"10.25259\/SNI_642_2022\/ref-3","doi-asserted-by":"crossref","first-page":"e988","DOI":"10.1016\/j.wneu.2019.07.055","article-title":"Pituitary apoplexy: Results of surgical and conservative management clinical series and review of literature","volume":"130","author":"Almeida","year":"2019","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2265.2004.02162.x","article-title":"Acute management of pituitary apoplexy-surgery or conservative management?","volume":"61","author":"Ayuk","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.25259\/SNI_642_2022\/ref-5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12020-014-0359-y","article-title":"Pituitary apoplexy","volume":"48","author":"Bi","year":"2015","journal-title":"Endocrine"},{"key":"10.25259\/SNI_642_2022\/ref-6","first-page":"602","article-title":"A retrospective analysis of pituitary apoplexy","volume":"33","author":"Bills","year":"1993","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_642_2022\/ref-7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"10.25259\/SNI_642_2022\/ref-8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cen.12307","article-title":"Presentation, management and outcomes in acute pituitary apoplexy: A large single center experience from the United Kingdom","volume":"80","author":"Bujawansa","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_642_2022\/ref-9","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1530\/EJE-14-0794","article-title":"Management of endocrine disease: Pituitary tumor apoplexy","volume":"172","author":"Capatina","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/SNI_642_2022\/ref-10","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/02688697.2020.1812523","article-title":"Pituitary apoplexy: How to define safe boundaries of conservative management? Early and long term outcomes from a single UK tertiary neurosurgical unit","volume":"35","author":"Cavalli","year":"2021","journal-title":"Br J Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-006-9148-7","article-title":"Surgical treatment for severe visual compromised patients after pituitary apoplexy","volume":"80","author":"Chuang","year":"2006","journal-title":"J Neurooncol"},{"key":"10.25259\/SNI_642_2022\/ref-12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/02841859709171238","article-title":"SIPAP-a new MR classification for pituitary adenomas. Suprasellar, infrasellar, parasellar, anterior and posterior","volume":"38","author":"Edal","year":"1997","journal-title":"Acta Radiol"},{"key":"10.25259\/SNI_642_2022\/ref-13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/cen.13075","article-title":"Pituitary apoplexy-bespoke patient management allows good clinical outcome","volume":"85","author":"Giritharan","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.25259\/SNI_642_2022\/ref-14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.wneu.2017.08.131","article-title":"Endoscopic endonasal surgery for treatment of pituitary apoplexy: 16 years of experience in a specialized pituitary center","volume":"108","author":"Gondim","year":"2017","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-15","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1097\/01.mlg.0000234933.37779.e4","article-title":"A novel reconstructive technique after endoscopic expanded endonasal approaches: Vascular pedicle nasoseptal flap","volume":"116","author":"Hadad","year":"2006","journal-title":"Laryngoscope"},{"key":"10.25259\/SNI_642_2022\/ref-16","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.wneu.2014.06.005","article-title":"Pituitary apoplexy: Large surgical series with grading system","volume":"82","author":"Jho","year":"2014","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-17","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space. A magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_642_2022\/ref-18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-10-0651","article-title":"Pituitary apoplexy re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome","volume":"164","author":"Moller-Goede","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.25259\/SNI_642_2022\/ref-19","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1016\/j.wneu.2020.01.204","article-title":"Pituitary apoplexy case series: Outcomes after endoscopic endonasal transsphenoidal surgery at a single tertiary center","volume":"137","author":"Pangal","year":"2020","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.25259\/SNI_642_2022\/ref-21","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1210\/jc.2013-1249","article-title":"The prevalence and natural history of pituitary hemorrhage in prolactinoma","volume":"98","author":"Sarwar","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.25259\/SNI_642_2022\/ref-22","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1227\/01.neu.0000303191.57178.2a","article-title":"Clinical relevance of precipitating factors in pituitary apoplexy","volume":"61","author":"Semple","year":"2007","journal-title":"Neurosurgery"},{"key":"10.25259\/SNI_642_2022\/ref-23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11102-005-1050-3","article-title":"Pituitary apoplexy: A review of clinical presentation, management and outcome in 45 cases","volume":"7","author":"Sibal","year":"2004","journal-title":"Pituitary"},{"key":"10.25259\/SNI_642_2022\/ref-24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3171\/2014.10.JNS141204","article-title":"Management and outcomes of pituitary apoplexy","volume":"122","author":"Singh","year":"2015","journal-title":"J Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0039-3400220","article-title":"Long term outcomes of pituitary gland preservation in pituitary macrodenoma apoplexy: Case series and review of literature","volume":"82","author":"Souter","year":"2021","journal-title":"J Neurol Surg B Skull Base"},{"key":"10.25259\/SNI_642_2022\/ref-26","doi-asserted-by":"crossref","first-page":"15330338211043032","DOI":"10.1177\/15330338211043032","article-title":"Endoscopic endonasal transsphenoidal approach for the surgical treatment of pituitary apoplexy and clinical outcomes","volume":"20","author":"Sun","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.25259\/SNI_642_2022\/ref-27","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/j.wneu.2017.12.103","article-title":"Pituitary apoplexy: Should endoscopic surgery be the gold standard?","volume":"111","author":"Teixeira","year":"2018","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-28","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/foc.2004.16.4.7","article-title":"Pituitary tumor apoplexy: Characteristics, treatment and outcomes","volume":"16","author":"Verrees","year":"2004","journal-title":"Neurosurg Focus"},{"key":"10.25259\/SNI_642_2022\/ref-29","first-page":"e357","article-title":"Endoscopic endonasal transsphenoidal treatment of pituitary apoplexy: Outcomes in a series of 20 patients","volume":"7","author":"Yang","year":"2015","journal-title":"Cureus"},{"key":"10.25259\/SNI_642_2022\/ref-30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.wneu.2016.09.052","article-title":"Time course of symptomatic recovery after endoscopic transsphenoidal surgery for pituitary adenoma apoplexy in the modern era","volume":"96","author":"Zaidi","year":"2016","journal-title":"World Neurosurg"},{"key":"10.25259\/SNI_642_2022\/ref-31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/neuros\/nyx073","article-title":"Preoperative stratification of transsphenoidal pituitary surgery based on surgical urgency","volume":"81","author":"Zaidi","year":"2017","journal-title":"Neurosurgery"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/determinants-of-visual-and-endocrinological-outcome-after-early-endoscopic-endonasal-surgery-for-pituitary-apoplexy\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/determinants-of-visual-and-endocrinological-outcome-after-early-endoscopic-endonasal-surgery-for-pituitary-apoplexy\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T09:31:33Z","timestamp":1728034293000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/determinants-of-visual-and-endocrinological-outcome-after-early-endoscopic-endonasal-surgery-for-pituitary-apoplexy\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":31,"alternative-id":["10.25259\/SNI_642_2022"],"URL":"https:\/\/doi.org\/10.25259\/sni_642_2022","relation":{},"ISSN":["2152-7806"],"issn-type":[{"value":"2152-7806","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"433"}}